Here's something you might be interested in.
Ask a Hipster — Advice you didn't know you needed
Big Screen — Movie commentary
Blurt — Music's inside track
Booze News — San Diego spirits
Classical Music — Immortal beauty
Classifieds — Free and easy
Cover Stories — Front-page features
Drinks All Around — Bartenders' drink recipes
Excerpts — Literary and spiritual excerpts
Feast! — Food & drink reviews
Feature Stories — Local news & stories
Fishing Report — What’s getting hooked from ship and shore
From the Archives — Spotlight on the past
Golden Dreams — Talk of the town
The Gonzo Report — Making the musical scene, or at least reporting from it
Letters — Our inbox
Movies@Home — Local movie buffs share favorites
Movie Reviews — Our critics' picks and pans
Musician Interviews — Up close with local artists
Neighborhood News from Stringers — Hyperlocal news
News Ticker — News & politics
Obermeyer — San Diego politics illustrated
Outdoors — Weekly changes in flora and fauna
Overheard in San Diego — Eavesdropping illustrated
Poetry — The old and the new
Reader Travel — Travel section built by travelers
Reading — The hunt for intellectuals
Roam-O-Rama — SoCal's best hiking/biking trails
San Diego Beer — Inside San Diego suds
SD on the QT — Almost factual news
Sheep and Goats — Places of worship
Special Issues — The best of
Street Style — San Diego streets have style
Surf Diego — Real stories from those braving the waves
Theater — On stage in San Diego this week
Tin Fork — Silver spoon alternative
Under the Radar — Matt Potter's undercover work
Unforgettable — Long-ago San Diego
Unreal Estate — San Diego's priciest pads
Your Week — Daily event picks
300 percent returns? No.
Prometheus head James Catipay pleads guilty
James Catipay pleaded guilty yesterday (October 26) to defrauding investors through a plan to recruit plaintiffs for lawsuits against pharmaceutical firms. He was promising returns of 100 percent to 300 percent per year. His company, Prometheus, collected almost $12 million from 200 investors. Many of them were retired and lost their entire investments.
Catipay told potential investors that he would use their money to recruit potential plaintiffs who would sue pharmaceutical companies. The proceeds from these tort lawsuits would go to the investors, Catipay claimed.
According to court documents, he gave much false information to investors. Here are some of the falsehoods: that investors could collect their funds at any time; funds were available to pay the fat returns as well as redemptions; and their investments were secured by enforceable liens. A court-appointed receiver has taken over the company.
Here's something you might be interested in.
300 percent returns? No.
Prometheus head James Catipay pleads guilty
300 percent returns? No.
Prometheus head James Catipay pleads guilty
James Catipay pleaded guilty yesterday (October 26) to defrauding investors through a plan to recruit plaintiffs for lawsuits against pharmaceutical firms. He was promising returns of 100 percent to 300 percent per year. His company, Prometheus, collected almost $12 million from 200 investors. Many of them were retired and lost their entire investments.
Catipay told potential investors that he would use their money to recruit potential plaintiffs who would sue pharmaceutical companies. The proceeds from these tort lawsuits would go to the investors, Catipay claimed.
According to court documents, he gave much false information to investors. Here are some of the falsehoods: that investors could collect their funds at any time; funds were available to pay the fat returns as well as redemptions; and their investments were secured by enforceable liens. A court-appointed receiver has taken over the company.
Comments